Compounded Pain Cream Prices Rise Eight-Fold, OIG Urges CMS To Act

August 14, 2018 at 3:40 PM
The price of compounded topical ointments are skyrocketing and Medicare is picking up the tab, according to a new report from HHS’ Office of Inspector General that calls on CMS to step up its oversight of potentially fraudulent billing. One compounding attorney says this is just the latest turn in a years-long saga, which previously pitted compounders against the Department of Defense. The report, which focuses on potential waste fraud and abuse, suggests CMS do more to ensure compounded drugs...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.